目的:基于我们在《汉斯》2024,13(7)期刊发表“中西医联合用药对照单纯西药改善不孕症患者子宫内膜容受性疗效的系统评价及Meta分析”一文撰写本篇文章,进一步分析中药改善ER的用药规律及特点,形成姊妹篇,用以完善方法与结论。方法:手工检索姊篇所包含的15篇文献,统计所用中药方药,依据功效特点分为两组进行比较分析用药规律及特点:A组补肾填精益气养血类(有8项研究)、B组补肾活血化瘀类(有7项研究)。两组18篇文献,共纳入28个药方,归纳中药20种,单药用药次数共计217次,提取可对比分析的有效文献15篇,通过分类比较药物基本信息,将研究数据输入Excel,统计分析使用SPSS17.0。结果:文献共使用28种药方,高频用药有菟丝子(选用25次)、当归(选用18次),其中补肾中药占比为43.2%,益气中药占比27.2%,活血化瘀类药占比20.7%。A组补肾基础上偏重于健脾益气(益气21.4%,养血14.3%,化瘀8.3%),化瘀药局限(药量占比:5/76 = 6.6%);后者补肾基础上偏重于活血化瘀消症(化瘀26.4%,养血27.1%,益气16.3%),化瘀药种类繁多,频次高,剂量大,(药量占比:25/91 = 27.5%)近三成比重。结论:中药改善ER低下性不孕,从补肾健脾疏肝化瘀等多靶点调节体质,可减轻临床症状,降低西药不良反应,提高妊娠率。临床应用简便易行,副作用少,起到未孕助孕,已孕安胎之效,总之中药以补肾为主,活血化瘀为辅,补泻兼施各有法度,化瘀药运用约占用药比重1/5,颇具意义。Objective: Based on “A Systematic Review and Meta-Analysis of the Efficacy of Traditional Chinese Medicine Combined with Western Medicine against Western Medicine Alone in Improving Endometrium Receptivity in Infertility Patients” published in the journal Hans 2024, 13 (7), this paper was written to further analyze the medication rules and characteristics of Chinese medicine in improving ER, and form a companion paper to improve the methods and conc
